Home / Latest Reports / Continuous Glucose Monitoring Cgm Systems Market

Continuous Glucose Monitoring (CGM) Systems Market By Product and End-user - Global Industry Analysis & Forecast to 2027

Published On : October 2018 Pages : 180 Category: Medical Devices Report Code : HC101551

Request Sample Inquiry Before Buying Request for Customization Check Discount

Continuous Glucose Monitoring (CGM) Systems Market By Product (Sensors, Transmitters and Receivers, Insulin Pumps) End User (Homecare diagnostics, Hospitals, Others) - Global Industry Analysis & Forecast to 2027

Industry Outlook and Trend Analysis

The Continuous Glucose Monitoring (CGM) Systems Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. Glucose monitoring (CGM) gadgets has been driving the market. CGM devices are minimally invasive and offer a simple and compelling approach for the management of diabetes. They can likewise identify intense changes in blood glucose level, subsequently avoiding hypoglycemic conditions. These devices encourage examination of blood glucose levels at various time interims with the assistance of a sensor. Separate readings put into to diabetes management software through a remote system enable patients to comprehend the illness better, subsequently helping them to oversee it in a more successful manner.

Market Segmentation

By product the transmitters and receivers are the most important part of these devices, they represented for the biggest share of the market. Homecare settings segment ruled the global market and is foreseen to encounter the highest CAGR over the forecast period.

Regional Insights

The North American region is anticipated to dominate the global market. Rising cases of diabetes and initiatives made by the national government to manage the disease at large are foreseen to boost the region’s growth.

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Southeast Asia
    • Rest of Asia-Pacific
  • South America
    • Brazil
    • Argentina
    • Columbia
    • Rest of South America
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • Nigeria
    • South Africa
    • Rest of MEA

Competitive Analysis                         

The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.

  • Abbott Laboratories
  • Animas Corporation
  • Ypsomed AG
  • Roche Diagnostics
  • Dexcom Inc.
  • Medtronic Inc.
  • Novo Nordisk
  • GlySens Incorporated

Some of the key questions answered by the report are:

  • What was the market size in 2017 and forecast from 2017 to 2027?
  • What will be the industry market growth from 2017 to 2027?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

·         Continuous Glucose Monitoring (CGM) Systems Market, By Product, Estimates and Forecast, 2017-2027 ($Million)

·         Sensors

·         Transmitters and Receivers

·         Insulin Pumps

·         Continuous Glucose Monitoring (CGM) Systems Market, By End User, Estimates and Forecast, 2017-2027 ($Million)

·         Homecare diagnostics

·         Hospitals

·         Others

·         Continuous Glucose Monitoring (CGM) Systems Market, By Region, Estimates and Forecast, 2017-2027 ($Million)

·         North America

§  North America Continuous Glucose Monitoring (CGM) Systems Market, By Country

o    U.S. Continuous Glucose Monitoring (CGM) Systems Market

o    Canada Continuous Glucose Monitoring (CGM) Systems Market

o    Mexico Continuous Glucose Monitoring (CGM) Systems Market

·         Europe

§  Europe Continuous Glucose Monitoring (CGM) Systems Market, By Country

o    Germany Continuous Glucose Monitoring (CGM) Systems Market

o    UK Continuous Glucose Monitoring (CGM) Systems Market

o    France Continuous Glucose Monitoring (CGM) Systems Market

o    Russia Continuous Glucose Monitoring (CGM) Systems Market

o    Italy Continuous Glucose Monitoring (CGM) Systems Market

o    Rest of Europe Continuous Glucose Monitoring (CGM) Systems Market

·         Asia-Pacific

§  Asia-Pacific Continuous Glucose Monitoring (CGM) Systems Market, By Country

o    China Continuous Glucose Monitoring (CGM) Systems Market

o    Japan Continuous Glucose Monitoring (CGM) Systems Market

o    South Korea Continuous Glucose Monitoring (CGM) Systems Market

o    India Continuous Glucose Monitoring (CGM) Systems Market

o    Southeast Asia Continuous Glucose Monitoring (CGM) Systems Market

o    Rest of Asia-Pacific Continuous Glucose Monitoring (CGM) Systems Market

·         South America

§  South America Continuous Glucose Monitoring (CGM) Systems Market

o    Brazil Continuous Glucose Monitoring (CGM) Systems Market

o    Argentina Continuous Glucose Monitoring (CGM) Systems Market

o    Columbia Continuous Glucose Monitoring (CGM) Systems Market

o    Rest of South America Continuous Glucose Monitoring (CGM) Systems Market

·         Middle East and Africa

§  Middle East and Africa Continuous Glucose Monitoring (CGM) Systems Market

o    Saudi Arabia Continuous Glucose Monitoring (CGM) Systems Market

o    UAE Continuous Glucose Monitoring (CGM) Systems Market

o    Egypt Continuous Glucose Monitoring (CGM) Systems Market

o    Nigeria Continuous Glucose Monitoring (CGM) Systems Market

o    South Africa Continuous Glucose Monitoring (CGM) Systems Market

o    Rest of MEA Continuous Glucose Monitoring (CGM) Systems Market

Table of Contents:

1.       Introduction

1.1.     Report Description

2.       Executive Summary

2.1.     Key Highlights

3.       Market Overview

3.1.     Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.     Market Dynamics

3.2.1.  Drivers

3.2.2.  Restraints

3.2.3.  Opportunities

3.3.     SWOT Analysis

4.       Market Analysis by Regions

4.1.     North America (United States, Canada and Mexico)

4.1.1.  United States Market Status and Outlook (2017-2027)

4.1.2.  Canada Market Status and Outlook (2017-2027)

4.1.3.  Mexico Market Status and Outlook (2017-2027)

4.2.     Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1.  Germany Market Status and Outlook (2017-2027)

4.2.2.  France Market Status and Outlook (2017-2027)

4.2.3.  UK Market Status and Outlook (2017-2027)

4.2.4.  Russia Market Status and Outlook (2017-2027)

4.2.5.  Italy Market Status and Outlook (2017-2027)

4.2.6.  Rest of Europe Market Status and Outlook (2017-2027)

4.3.     Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1.  China Market Status and Outlook (2017-2027)

4.3.2.  Japan Market Status and Outlook (2017-2027)

4.3.3.  Korea Market Status and Outlook (2017-2027)

4.3.4.  India Market Status and Outlook (2017-2027)

4.3.5.  Southeast Asia Market Status and Outlook (2017-2027)

4.3.6.  Rest of Asia-Pacific Market Status and Outlook (2017-2027)

4.4.     South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1.  Brazil Market Status and Outlook (2017-2027)

4.4.2.  Argentina Market Status and Outlook (2017-2027)

4.4.3.  Columbia Market Status and Outlook (2017-2027)

4.4.4.  Rest of South America Market Status and Outlook (2017-2027)

4.5.     Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1.  Saudi Arabia Market Status and Outlook (2017-2027)

4.5.2.  United Arab Emirates Market Status and Outlook (2017-2027)

4.5.3.  Egypt Market Status and Outlook (2017-2027)

4.5.4.  Nigeria Market Status and Outlook (2017-2027)

4.5.5.  South Africa Market Status and Outlook (2017-2027)

4.5.6.  Turkey Market Status and Outlook (2017-2027)

4.5.7.  Rest of Middle East and Africa Market Status and Outlook (2017-2027)

5.       Continuous Glucose Monitoring (CGM) Systems Market, By Product

5.1.     Introduction

5.2.     Global Continuous Glucose Monitoring (CGM) Systems Revenue and Market Share by Product (2017-2027)

5.2.1.  Global Continuous Glucose Monitoring (CGM) Systems Revenue and Revenue Share by Product (2017-2027)

5.3.     Sensors

5.3.1.  Global Sensors Revenue and Growth Rate (2017-2027)

5.4.     Transmitters and Receivers

5.4.1.  Global Transmitters and Receivers Revenue and Growth Rate (2017-2027)

5.5.     Insulin Pumps

5.5.1.  Global Insulin Pumps Revenue and Growth Rate (2017-2027)

6.       Continuous Glucose Monitoring (CGM) Systems Market, By End User

6.1.     Introduction

6.2.     Global Continuous Glucose Monitoring (CGM) Systems Revenue and Market Share by End User (2017-2027)

6.2.1.  Global Continuous Glucose Monitoring (CGM) Systems Revenue and Revenue Share by End User (2017-2027)

6.3.     Homecare diagnostics

6.3.1.  Global Homecare diagnostics Revenue and Growth Rate (2017-2027)

6.4.     Hospitals

6.4.1.  Global Hospitals Revenue and Growth Rate (2017-2027)

6.5.     Others

6.5.1.  Global Others Revenue and Growth Rate (2017-2027)

7.       Continuous Glucose Monitoring (CGM) Systems Market, By Region

7.1.     Introduction

7.2.     Global Continuous Glucose Monitoring (CGM) Systems Revenue and Market Share by Regions

7.2.1.  Global Continuous Glucose Monitoring (CGM) Systems Revenue by Regions (2017-2027)

7.3.     North America Continuous Glucose Monitoring (CGM) Systems by Countries

7.3.1.  North America Continuous Glucose Monitoring (CGM) Systems Revenue and Growth Rate (2017-2027)

7.3.2.  North America Continuous Glucose Monitoring (CGM) Systems Revenue (Million USD) by Countries (2017-2027)

7.3.3.  United States

7.3.3.1.  United States Continuous Glucose Monitoring (CGM) Systems Revenue (Millions USD) and Growth Rate (2017-2027)

7.3.4.  Canada

7.3.4.1.  Canada Continuous Glucose Monitoring (CGM) Systems Revenue (Millions USD) and Growth Rate (2017-2027)

7.3.5.  Mexico

7.3.5.1.  Mexico Continuous Glucose Monitoring (CGM) Systems Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.     Europe Continuous Glucose Monitoring (CGM) Systems by Countries

7.4.1.  Europe Continuous Glucose Monitoring (CGM) Systems Revenue and Growth Rate (2017-2027)

7.4.2.  Europe Continuous Glucose Monitoring (CGM) Systems Revenue (Million USD) by Countries (2017-2027)

7.4.3.  Germany

7.4.3.1.  Germany Continuous Glucose Monitoring (CGM) Systems Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.4.  France

7.4.4.1.  France Continuous Glucose Monitoring (CGM) Systems Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.5.  UK

7.4.5.1.  UK Continuous Glucose Monitoring (CGM) Systems Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.6.  Russia

7.4.6.1.  Russia Continuous Glucose Monitoring (CGM) Systems Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.7.  Italy

7.4.7.1.  Italy Continuous Glucose Monitoring (CGM) Systems Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.8.  Rest of Europe

7.4.8.1.  Rest of Europe Continuous Glucose Monitoring (CGM) Systems Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.     Asia-Pacific Continuous Glucose Monitoring (CGM) Systems by Countries

7.5.1.  Asia-Pacific Continuous Glucose Monitoring (CGM) Systems Revenue and Growth Rate (2017-2027)

7.5.2.  Asia-Pacific Continuous Glucose Monitoring (CGM) Systems Revenue (Million USD) by Countries (2017-2027)

7.5.3.  China

7.5.3.1.  China Continuous Glucose Monitoring (CGM) Systems Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.4.  Japan

7.5.4.1.  Japan Continuous Glucose Monitoring (CGM) Systems Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.5.  Korea

7.5.5.1.  Korea Continuous Glucose Monitoring (CGM) Systems Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.6.  India

7.5.6.1.  India Continuous Glucose Monitoring (CGM) Systems Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.7.  Southeast Asia

7.5.7.1.  Southeast Asia Continuous Glucose Monitoring (CGM) Systems Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.8.  Rest of Asia-Pacific

7.5.8.1.  Rest of Asia-Pacific Continuous Glucose Monitoring (CGM) Systems Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.     South America Continuous Glucose Monitoring (CGM) Systems by Countries

7.6.1.  South America Continuous Glucose Monitoring (CGM) Systems Revenue and Growth Rate (2017-2027)

7.6.2.  South America Continuous Glucose Monitoring (CGM) Systems Revenue (Million USD) by Countries (2017-2027)

7.6.3.  Brazil

7.6.3.1.  Brazil Continuous Glucose Monitoring (CGM) Systems Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.4.  Argentina

7.6.4.1.  Argentina Continuous Glucose Monitoring (CGM) Systems Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.5.  Columbia

7.6.5.1.  Columbia Continuous Glucose Monitoring (CGM) Systems Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.6.  Rest of South America

7.6.6.1.  Rest of South America Continuous Glucose Monitoring (CGM) Systems Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.     Middle East and Africa Continuous Glucose Monitoring (CGM) Systems by Countries

7.7.1.  Middle East and Africa Continuous Glucose Monitoring (CGM) Systems Revenue and Growth Rate (2017-2027)

7.7.2.  Middle East and Africa Continuous Glucose Monitoring (CGM) Systems Revenue (Million USD) by Countries (2017-2027)

7.7.3.  Saudi Arabia

7.7.3.1.  Saudi Arabia Continuous Glucose Monitoring (CGM) Systems Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.4.  United Arab Emirates

7.7.4.1.  United Arab Emirates Continuous Glucose Monitoring (CGM) Systems Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.5.  Egypt

7.7.5.1.  Egypt Continuous Glucose Monitoring (CGM) Systems Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.6.  Nigeria

7.7.6.1.  Nigeria Continuous Glucose Monitoring (CGM) Systems Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.7.  South Africa

7.7.7.1.  South Africa Continuous Glucose Monitoring (CGM) Systems Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.8.  Turkey

7.7.8.1.  Turkey Continuous Glucose Monitoring (CGM) Systems Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.9.  Rest of Middle East and Africa

7.7.9.1.  Rest of Middle East and Africa Continuous Glucose Monitoring (CGM) Systems Revenue (Millions USD) and Growth Rate (2017-2027)

8.       Company Profiles

8.1.     Abbott Laboratories

8.1.1.  Business Overview

8.1.2.   Service Portfolio

8.1.3.  Strategic Developments

8.1.4.   Revenue and Market Share

8.2.     Animas Corporation

8.2.1.  Business Overview

8.2.2.   Service Portfolio

8.2.3.  Strategic Developments

8.2.4.   Revenue and Market Share

8.3.     Ypsomed AG

8.3.1.  Business Overview

8.3.2.   Service Portfolio

8.3.3.  Strategic Developments

8.3.4.   Revenue and Market Share

8.4.     Roche Diagnostics

8.4.1.  Business Overview

8.4.2.   Service Portfolio

8.4.3.  Strategic Developments

8.4.4.   Revenue and Market Share

8.5.     Dexcom Inc.

8.5.1.  Business Overview

8.5.2.   Service Portfolio

8.5.3.  Strategic Developments

8.5.4.   Revenue and Market Share

8.6.     Medtronic Inc.

8.6.1.  Business Overview

8.6.2.   Service Portfolio

8.6.3.  Strategic Developments

8.6.4.   Revenue and Market Share

8.7.     Novo Nordisk

8.7.1.  Business Overview

8.7.2.   Service Portfolio

8.7.3.  Strategic Developments

8.7.4.   Revenue and Market Share

8.8.     GlySens Incorporated

8.8.1.  Business Overview

8.8.2.   Service Portfolio

8.8.3.  Strategic Developments

8.8.4.   Revenue and Market Share

9.       Global Continuous Glucose Monitoring (CGM) Systems Market Competition, by Manufacturer

9.1.     Global Continuous Glucose Monitoring (CGM) Systems Revenue and Market Share by Manufacturer (2017-2017)

9.2.     Global Continuous Glucose Monitoring (CGM) Systems Price By Region (2017-2017)

9.3.     Top 5 Continuous Glucose Monitoring (CGM) Systems Manufacturer Market Share

9.4.     Market Competition Trend

10.    Continuous Glucose Monitoring (CGM) Systems Market Forecast (2017-2027)

10.1. Global Continuous Glucose Monitoring (CGM) Systems Revenue (Millions USD) and Growth Rate (2017-2027)

10.2. Continuous Glucose Monitoring (CGM) Systems Market Forecast by Regions (2017-2027)

10.2.1.      North America Continuous Glucose Monitoring (CGM) Systems Market Forecast (2017-2027)

10.2.1.1. United States Continuous Glucose Monitoring (CGM) Systems Market Forecast (2017-2027)

10.2.1.2. Canada Continuous Glucose Monitoring (CGM) Systems Market Forecast (2017-2027)

10.2.1.3. Mexico Continuous Glucose Monitoring (CGM) Systems Market Forecast (2017-2027)

10.2.2.      Europe Continuous Glucose Monitoring (CGM) Systems Market Forecast (2017-2027)

10.2.2.1. Germany Continuous Glucose Monitoring (CGM) Systems Market Forecast (2017-2027)

10.2.2.2. France Continuous Glucose Monitoring (CGM) Systems Market Forecast (2017-2027)

10.2.2.3. UK Continuous Glucose Monitoring (CGM) Systems Market Forecast (2017-2027)

10.2.2.4. Russia Continuous Glucose Monitoring (CGM) Systems Market Forecast (2017-2027)

10.2.2.5. Italy Continuous Glucose Monitoring (CGM) Systems Market Forecast (2017-2027)

10.2.2.6. Rest of Europe Continuous Glucose Monitoring (CGM) Systems Market Forecast (2017-2027)

10.2.3.      Asia-Pacific Continuous Glucose Monitoring (CGM) Systems Market Forecast (2017-2027)

10.2.3.1. China Continuous Glucose Monitoring (CGM) Systems Market Forecast (2017-2027)

10.2.3.2. Japan Continuous Glucose Monitoring (CGM) Systems Market Forecast (2017-2027)

10.2.3.3. Korea Continuous Glucose Monitoring (CGM) Systems Market Forecast (2017-2027)

10.2.3.4. India Continuous Glucose Monitoring (CGM) Systems Market Forecast (2017-2027)

10.2.3.5. Southeast Asia Continuous Glucose Monitoring (CGM) Systems Market Forecast (2017-2027)

10.2.3.6. Rest of Asia-Pacific Continuous Glucose Monitoring (CGM) Systems Market Forecast (2017-2027)

10.2.4.      South America Continuous Glucose Monitoring (CGM) Systems Market Forecast (2017-2027)

10.2.4.1. Brazil Continuous Glucose Monitoring (CGM) Systems Market Forecast (2017-2027)

10.2.4.2. Argentina Continuous Glucose Monitoring (CGM) Systems Market Forecast (2017-2027)

10.2.4.3. Columbia Continuous Glucose Monitoring (CGM) Systems Market Forecast (2017-2027)

10.2.4.4. Rest of South America Continuous Glucose Monitoring (CGM) Systems Market Forecast (2017-2027)

10.2.5.      Middle East and Africa Continuous Glucose Monitoring (CGM) Systems Market Forecast (2017-2027)

10.2.5.1. Saudi Arabia Continuous Glucose Monitoring (CGM) Systems Market Forecast (2017-2027)

10.2.5.2. United Arab Emirates Continuous Glucose Monitoring (CGM) Systems Market Forecast (2017-2027)

10.2.5.3. Egypt Continuous Glucose Monitoring (CGM) Systems Market Forecast (2017-2027)

10.2.5.4. Nigeria Continuous Glucose Monitoring (CGM) Systems Market Forecast (2017-2027)

10.2.5.5. South Africa Continuous Glucose Monitoring (CGM) Systems Market Forecast (2017-2027)

10.2.5.6. Turkey Continuous Glucose Monitoring (CGM) Systems Market Forecast (2017-2027)

10.2.5.7. Rest of Middle East and Africa Continuous Glucose Monitoring (CGM) Systems Market Forecast (2017-2027)

10.3. Continuous Glucose Monitoring (CGM) Systems Market Forecast by Product (2017-2027)

10.3.1.      Continuous Glucose Monitoring (CGM) Systems Forecast by Product (2017-2027)

10.3.2.      Continuous Glucose Monitoring (CGM) Systems Market Share Forecast by Product (2017-2027)

10.4. Continuous Glucose Monitoring (CGM) Systems Market Forecast by End User (2017-2027)

10.4.1.      Continuous Glucose Monitoring (CGM) Systems Forecast by End User (2017-2027)

10.4.2.      Continuous Glucose Monitoring (CGM) Systems Market Share Forecast by End User (2017-2027)

List of Tables

List of Tables and Figures:

Figure United States Continuous Glucose Monitoring (CGM) Systems Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Continuous Glucose Monitoring (CGM) Systems Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Continuous Glucose Monitoring (CGM) Systems Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Continuous Glucose Monitoring (CGM) Systems Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Continuous Glucose Monitoring (CGM) Systems Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Continuous Glucose Monitoring (CGM) Systems Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Continuous Glucose Monitoring (CGM) Systems Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Continuous Glucose Monitoring (CGM) Systems Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Continuous Glucose Monitoring (CGM) Systems Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Continuous Glucose Monitoring (CGM) Systems Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Continuous Glucose Monitoring (CGM) Systems Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Continuous Glucose Monitoring (CGM) Systems Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Continuous Glucose Monitoring (CGM) Systems Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Continuous Glucose Monitoring (CGM) Systems Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Continuous Glucose Monitoring (CGM) Systems Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Continuous Glucose Monitoring (CGM) Systems Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Continuous Glucose Monitoring (CGM) Systems Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Continuous Glucose Monitoring (CGM) Systems Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Continuous Glucose Monitoring (CGM) Systems Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Continuous Glucose Monitoring (CGM) Systems Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Continuous Glucose Monitoring (CGM) Systems Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Continuous Glucose Monitoring (CGM) Systems Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Continuous Glucose Monitoring (CGM) Systems Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Continuous Glucose Monitoring (CGM) Systems Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Continuous Glucose Monitoring (CGM) Systems Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Continuous Glucose Monitoring (CGM) Systems Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Continuous Glucose Monitoring (CGM) Systems Revenue and Revenue Share by Product (2017-2018)
Figure Global Sensors Revenue and Growth Rate (2017-2018)
Figure Global Transmitters and Receivers Revenue and Growth Rate (2017-2018)
Figure Global Insulin Pumps Revenue and Growth Rate (2017-2018)
Table Global Continuous Glucose Monitoring (CGM) Systems Revenue and Revenue Share by End User (2017-2018)
Figure Global Homecare diagnostics Revenue and Growth Rate (2017-2018)
Figure Global Hospitals Revenue and Growth Rate (2017-2018)
Figure Global Others Revenue and Growth Rate (2017-2018)
Table Global Continuous Glucose Monitoring (CGM) Systems Revenue by Regions (2017-2018)
Figure North America Continuous Glucose Monitoring (CGM) Systems Growth Rate (2017-2018)
Figure North America Continuous Glucose Monitoring (CGM) Systems Revenue and Growth Rate (2017-2018)
Figure North America Continuous Glucose Monitoring (CGM) Systems by Countries (2017-2018)
Figure North America Continuous Glucose Monitoring (CGM) Systems Revenue (Million USD) by Countries (2017-2018)
Figure United States Continuous Glucose Monitoring (CGM) Systems Growth Rate (2017-2018)
Figure United States Continuous Glucose Monitoring (CGM) Systems Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Continuous Glucose Monitoring (CGM) Systems Growth Rate (2017-2018)
Figure Canada Continuous Glucose Monitoring (CGM) Systems Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Continuous Glucose Monitoring (CGM) Systems Growth Rate (2017-2018)
Figure Mexico Continuous Glucose Monitoring (CGM) Systems Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Continuous Glucose Monitoring (CGM) Systems Growth Rate (2017-2018)
Figure Europe Continuous Glucose Monitoring (CGM) Systems Revenue and Growth Rate (2017-2018)
Figure Europe Continuous Glucose Monitoring (CGM) Systems by Countries (2017-2018)
Figure Europe Continuous Glucose Monitoring (CGM) Systems Revenue (Million USD) by Countries (2017-2018)
Figure Germany Continuous Glucose Monitoring (CGM) Systems Growth Rate (2017-2018)
Figure Germany Continuous Glucose Monitoring (CGM) Systems Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Continuous Glucose Monitoring (CGM) Systems Growth Rate (2017-2018)
Figure France Continuous Glucose Monitoring (CGM) Systems Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Continuous Glucose Monitoring (CGM) Systems Growth Rate (2017-2018)
Figure UK Continuous Glucose Monitoring (CGM) Systems Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Continuous Glucose Monitoring (CGM) Systems Growth Rate (2017-2018)
Figure Russia Continuous Glucose Monitoring (CGM) Systems Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Continuous Glucose Monitoring (CGM) Systems Growth Rate (2017-2018)
Figure Italy Continuous Glucose Monitoring (CGM) Systems Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Continuous Glucose Monitoring (CGM) Systems Growth Rate (2017-2018)
Figure Rest of Europe Continuous Glucose Monitoring (CGM) Systems Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Continuous Glucose Monitoring (CGM) Systems Growth Rate (2017-2018)
Figure Asia-Pacific Continuous Glucose Monitoring (CGM) Systems Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Continuous Glucose Monitoring (CGM) Systems by Countries (2017-2018)
Figure Asia-Pacific Continuous Glucose Monitoring (CGM) Systems Revenue (Million USD) by Countries (2017-2018)
Figure China Continuous Glucose Monitoring (CGM) Systems Growth Rate (2017-2018)
Figure China Continuous Glucose Monitoring (CGM) Systems Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Continuous Glucose Monitoring (CGM) Systems Growth Rate (2017-2018)
Figure Japan Continuous Glucose Monitoring (CGM) Systems Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Continuous Glucose Monitoring (CGM) Systems Growth Rate (2017-2018)
Figure Korea Continuous Glucose Monitoring (CGM) Systems Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Continuous Glucose Monitoring (CGM) Systems Growth Rate (2017-2018)
Figure India Continuous Glucose Monitoring (CGM) Systems Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Continuous Glucose Monitoring (CGM) Systems Growth Rate (2017-2018)
Figure Southeast Asia Continuous Glucose Monitoring (CGM) Systems Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Continuous Glucose Monitoring (CGM) Systems Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Continuous Glucose Monitoring (CGM) Systems Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Continuous Glucose Monitoring (CGM) Systems Growth Rate (2017-2018)
Figure South America Continuous Glucose Monitoring (CGM) Systems Revenue and Growth Rate (2017-2018)
Figure South America Continuous Glucose Monitoring (CGM) Systems by Countries (2017-2018)
Figure South America Continuous Glucose Monitoring (CGM) Systems Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Continuous Glucose Monitoring (CGM) Systems Growth Rate (2017-2018)
Figure Brazil Continuous Glucose Monitoring (CGM) Systems Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Continuous Glucose Monitoring (CGM) Systems Growth Rate (2017-2018)
Figure Argentina Continuous Glucose Monitoring (CGM) Systems Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Continuous Glucose Monitoring (CGM) Systems Growth Rate (2017-2018)
Figure Columbia Continuous Glucose Monitoring (CGM) Systems Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Continuous Glucose Monitoring (CGM) Systems Growth Rate (2017-2018)
Figure Rest of South America Continuous Glucose Monitoring (CGM) Systems Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Continuous Glucose Monitoring (CGM) Systems Growth Rate (2017-2018)
Figure Middle East and Africa Continuous Glucose Monitoring (CGM) Systems Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Continuous Glucose Monitoring (CGM) Systems by Countries (2017-2018)
Figure Middle East and Africa Continuous Glucose Monitoring (CGM) Systems Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Continuous Glucose Monitoring (CGM) Systems Growth Rate (2017-2018)
Figure Saudi Arabia Continuous Glucose Monitoring (CGM) Systems Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Continuous Glucose Monitoring (CGM) Systems Growth Rate (2017-2018)
Figure United Arab Emirates Continuous Glucose Monitoring (CGM) Systems Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Continuous Glucose Monitoring (CGM) Systems Growth Rate (2017-2018)
Figure Egypt Continuous Glucose Monitoring (CGM) Systems Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Continuous Glucose Monitoring (CGM) Systems Growth Rate (2017-2018)
Figure Nigeria Continuous Glucose Monitoring (CGM) Systems Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Continuous Glucose Monitoring (CGM) Systems Growth Rate (2017-2018)
Figure South Africa Continuous Glucose Monitoring (CGM) Systems Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Continuous Glucose Monitoring (CGM) Systems Growth Rate (2017-2018)
Figure Turkey Continuous Glucose Monitoring (CGM) Systems Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Continuous Glucose Monitoring (CGM) Systems Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Continuous Glucose Monitoring (CGM) Systems Revenue (Millions USD) and Growth Rate (2017-2018)
Table Abbott Laboratories Continuous Glucose Monitoring (CGM) Systems Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Animas Corporation Continuous Glucose Monitoring (CGM) Systems Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Ypsomed AG Continuous Glucose Monitoring (CGM) Systems Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Roche Diagnostics Continuous Glucose Monitoring (CGM) Systems Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Dexcom Inc. Continuous Glucose Monitoring (CGM) Systems Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Medtronic Inc. Continuous Glucose Monitoring (CGM) Systems Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Novo Nordisk Continuous Glucose Monitoring (CGM) Systems Price, Revenue, Gross Margin and Market Share (2017-2017)
Table GlySens Incorporated Continuous Glucose Monitoring (CGM) Systems Price, Revenue, Gross Margin and Market Share (2017-2017)
Figure Global Continuous Glucose Monitoring (CGM) Systems Market Share by Manufacturer
Figure Global Continuous Glucose Monitoring (CGM) Systems Revenue and Market Share by Manufacturer
Table Global Continuous Glucose Monitoring (CGM) Systems Price by Region (2017-2017)
Figure Top 5 Continuous Glucose Monitoring (CGM) Systems Manufacturer (Revenue) Market Share
Figure Market Competition Trend
Figure Global Continuous Glucose Monitoring (CGM) Systems Revenue (Millions USD) and Growth Rate (2018-2025)
Table Continuous Glucose Monitoring (CGM) Systems Market Forecast by Regions (2018-2025)
Figure North America Continuous Glucose Monitoring (CGM) Systems Market Forecast (2018-2025)
Figure United States Continuous Glucose Monitoring (CGM) Systems Market Forecast (2018-2025)
Figure Canada Continuous Glucose Monitoring (CGM) Systems Market Forecast (2018-2025)
Figure Mexico Continuous Glucose Monitoring (CGM) Systems Market Forecast (2018-2025)
Figure Europe Continuous Glucose Monitoring (CGM) Systems Market Forecast (2018-2025)
Figure Germany Continuous Glucose Monitoring (CGM) Systems Market Forecast (2018-2025)
Figure France Continuous Glucose Monitoring (CGM) Systems Market Forecast (2018-2025)
Figure UK Continuous Glucose Monitoring (CGM) Systems Market Forecast (2018-2025)
Figure Russia Continuous Glucose Monitoring (CGM) Systems Market Forecast (2018-2025)
Figure Italy Continuous Glucose Monitoring (CGM) Systems Market Forecast (2018-2025)
Figure Rest of Europe Continuous Glucose Monitoring (CGM) Systems Market Forecast (2018-2025)
Figure Asia-Pacific Continuous Glucose Monitoring (CGM) Systems Market Forecast (2018-2025)
Figure China Continuous Glucose Monitoring (CGM) Systems Market Forecast (2018-2025)
Figure Japan Continuous Glucose Monitoring (CGM) Systems Market Forecast (2018-2025)
Figure Korea Continuous Glucose Monitoring (CGM) Systems Market Forecast (2018-2025)
Figure India Continuous Glucose Monitoring (CGM) Systems Market Forecast (2018-2025)
Figure Southeast Asia Continuous Glucose Monitoring (CGM) Systems Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Continuous Glucose Monitoring (CGM) Systems Market Forecast (2018-2025)
Figure South America Continuous Glucose Monitoring (CGM) Systems Market Forecast (2018-2025)
Figure Brazil Continuous Glucose Monitoring (CGM) Systems Market Forecast (2018-2025)
Figure Argentina Continuous Glucose Monitoring (CGM) Systems Market Forecast (2018-2025)
Figure Columbia Continuous Glucose Monitoring (CGM) Systems Market Forecast (2018-2025)
Figure Rest of South America Continuous Glucose Monitoring (CGM) Systems Market Forecast (2018-2025)
Figure Middle East and Africa Continuous Glucose Monitoring (CGM) Systems Market Forecast (2018-2025)
Figure Saudi Arabia Continuous Glucose Monitoring (CGM) Systems Market Forecast (2018-2025)
Figure United Arab Emirates Continuous Glucose Monitoring (CGM) Systems Market Forecast (2018-2025)
Figure Egypt Continuous Glucose Monitoring (CGM) Systems Market Forecast (2018-2025)
Figure Nigeria Continuous Glucose Monitoring (CGM) Systems Market Forecast (2018-2025)
Figure South Africa Continuous Glucose Monitoring (CGM) Systems Market Forecast (2018-2025)
Figure Turkey Continuous Glucose Monitoring (CGM) Systems Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Continuous Glucose Monitoring (CGM) Systems Market Forecast (2018-2025)
Figure Global Continuous Glucose Monitoring (CGM) Systems Forecast by Product (2018-2025)
Figure Global Continuous Glucose Monitoring (CGM) Systems Market Share Forecast by Product (2018-2025)
Figure Global Continuous Glucose Monitoring (CGM) Systems Forecast by Product (2018-2025)
Figure Global Continuous Glucose Monitoring (CGM) Systems Forecast by End User (2018-2025)
Figure Global Continuous Glucose Monitoring (CGM) Systems Market Share Forecast by End User (2018-2025)
Figure Global Continuous Glucose Monitoring (CGM) Systems Forecast by End User (2018-2025)

Please Note: Data related to the Companies are subject to Availability.

Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources
  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources
  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)
  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

License Type

For Any Assistance

*
*
*
*
*